Phase I study of gemcitabine and vinorelbine in nonsmall cell lung cancer (NSCLC)-elderly patients

被引:0
|
作者
Santomaggio, C
Portalone, L
Seebacher, C
Bazzicalupo, F
Soresi, E
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
136
引用
收藏
页码:81 / 81
页数:1
相关论文
共 50 条
  • [1] Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma -: A phase II study
    Lilenbaum, R
    Cano, R
    Schwartz, M
    Siegel, L
    Lutzky, J
    Lewis, M
    Krill, E
    Barreras, L
    Davila, E
    CANCER, 2000, 88 (03) : 557 - 562
  • [2] Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma -: A Phase II study
    Buccheri, G
    Ferrigno, D
    CANCER, 2000, 88 (12) : 2677 - 2685
  • [3] Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma -: A phase II study
    Kotiloglu, G
    Özyilkan, Ö
    CANCER, 2002, 94 (01) : 282 - 282
  • [4] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [5] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
  • [6] Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Nonsmall Cell Lung Cancer
    Hasturk, Serap
    Hatabay, Nilgun
    Ece, Ferah
    Karatasli, Meltem
    Hanta, Ismail
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 280 - 285
  • [7] PHASE-I STUDY OF VINORELBINE AND CARBOPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER
    JACOULET, P
    BRETON, JL
    WESTEEL, V
    MERCIER, M
    GARNIER, G
    DEPIERRE, A
    LUNG CANCER, 1995, 12 (03) : 247 - 257
  • [8] Phase I trial of oral S-1 plus gemcitabine in elderly patients with nonsmall cell lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Aoki, Haruka
    Kawata, Tadayoshi
    Utsugi, Mitsuyoshi
    Shimizu, Yasuo
    Shimizu, Kimihiro
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Mori, Masatomo
    ANTI-CANCER DRUGS, 2008, 19 (03) : 289 - 294
  • [9] Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: Phase II study
    Lee, S
    Lee, E
    Jeong, H
    Lee, S
    Kim, J
    Shin, C
    Shim, J
    Kang, K
    Yoo, S
    In, K
    LUNG CANCER, 2005, 49 : S255 - S255
  • [10] Phase I/II dose escalating study of gemcitabine and paclitaxel in nonsmall cell lung cancer (NSCLC): Preliminary report.
    O'Byrne, KJ
    Beare, S
    Shields, F
    Sharma, R
    Jeyapalan, K
    Steward, WP
    BRITISH JOURNAL OF CANCER, 1998, 78 : 9 - 9